995 related articles for article (PubMed ID: 26143603)
1. Sialic acid (SA)-modified selenium nanoparticles coated with a high blood-brain barrier permeability peptide-B6 peptide for potential use in Alzheimer's disease.
Yin T; Yang L; Liu Y; Zhou X; Sun J; Liu J
Acta Biomater; 2015 Oct; 25():172-83. PubMed ID: 26143603
[TBL] [Abstract][Full Text] [Related]
2. Unravelling the in vitro and in vivo potential of selenium nanoparticles in Alzheimer's disease: A bioanalytical review.
Vicente-Zurdo D; Rosales-Conrado N; León-González ME
Talanta; 2024 Mar; 269():125519. PubMed ID: 38086100
[TBL] [Abstract][Full Text] [Related]
3. B6 peptide-modified PEG-PLA nanoparticles for enhanced brain delivery of neuroprotective peptide.
Liu Z; Gao X; Kang T; Jiang M; Miao D; Gu G; Hu Q; Song Q; Yao L; Tu Y; Chen H; Jiang X; Chen J
Bioconjug Chem; 2013 Jun; 24(6):997-1007. PubMed ID: 23718945
[TBL] [Abstract][Full Text] [Related]
4. Oral Administration of Resveratrol-Selenium-Peptide Nanocomposites Alleviates Alzheimer's Disease-like Pathogenesis by Inhibiting Aβ Aggregation and Regulating Gut Microbiota.
Li C; Wang N; Zheng G; Yang L
ACS Appl Mater Interfaces; 2021 Oct; 13(39):46406-46420. PubMed ID: 34569225
[TBL] [Abstract][Full Text] [Related]
5. Ability of selenium species to inhibit metal-induced Aβ aggregation involved in the development of Alzheimer's disease.
Vicente-Zurdo D; Romero-Sánchez I; Rosales-Conrado N; León-González ME; Madrid Y
Anal Bioanal Chem; 2020 Sep; 412(24):6485-6497. PubMed ID: 32322953
[TBL] [Abstract][Full Text] [Related]
6. Dual-functional selenium nanoparticles bind to and inhibit amyloid β fiber formation in Alzheimer's disease.
Yang L; Sun J; Xie W; Liu Y; Liu J
J Mater Chem B; 2017 Aug; 5(30):5954-5967. PubMed ID: 32264352
[TBL] [Abstract][Full Text] [Related]
7. A comparative study of resveratrol and resveratrol-functional selenium nanoparticles: Inhibiting amyloid β aggregation and reactive oxygen species formation properties.
Yang L; Wang W; Chen J; Wang N; Zheng G
J Biomed Mater Res A; 2018 Dec; 106(12):3034-3041. PubMed ID: 30295993
[TBL] [Abstract][Full Text] [Related]
8. Detection of β-Amyloid by Sialic Acid Coated Bovine Serum Albumin Magnetic Nanoparticles in a Mouse Model of Alzheimer's Disease.
Nasr SH; Kouyoumdjian H; Mallett C; Ramadan S; Zhu DC; Shapiro EM; Huang X
Small; 2018 Jan; 14(3):. PubMed ID: 29134771
[TBL] [Abstract][Full Text] [Related]
9. Penetratin Peptide-Functionalized Gold Nanostars: Enhanced BBB Permeability and NIR Photothermal Treatment of Alzheimer's Disease Using Ultralow Irradiance.
Yin T; Xie W; Sun J; Yang L; Liu J
ACS Appl Mater Interfaces; 2016 Aug; 8(30):19291-302. PubMed ID: 27411476
[TBL] [Abstract][Full Text] [Related]
10. Multifunctional Selenium Nanoparticles with Different Surface Modifications Ameliorate Neuroinflammation through the Gut Microbiota-NLRP3 Inflammasome-Brain Axis in APP/PS1 Mice.
Yang L; Cui Y; Liang H; Li Z; Wang N; Wang Y; Zheng G
ACS Appl Mater Interfaces; 2022 Jul; 14(27):30557-30570. PubMed ID: 35758423
[TBL] [Abstract][Full Text] [Related]
11. Epigallocatechin-3-gallate (EGCG)-stabilized selenium nanoparticles coated with Tet-1 peptide to reduce amyloid-β aggregation and cytotoxicity.
Zhang J; Zhou X; Yu Q; Yang L; Sun D; Zhou Y; Liu J
ACS Appl Mater Interfaces; 2014 Jun; 6(11):8475-87. PubMed ID: 24758520
[TBL] [Abstract][Full Text] [Related]
12. High-Throughput Screening for Identification of Blood-Brain Barrier Integrity Enhancers: A Drug Repurposing Opportunity to Rectify Vascular Amyloid Toxicity.
Qosa H; Mohamed LA; Al Rihani SB; Batarseh YS; Duong QV; Keller JN; Kaddoumi A
J Alzheimers Dis; 2016 Jul; 53(4):1499-516. PubMed ID: 27392852
[TBL] [Abstract][Full Text] [Related]
13. Biomimetic ApoE-Reconstituted High Density Lipoprotein Nanocarrier for Blood-Brain Barrier Penetration and Amyloid Beta-Targeting Drug Delivery.
Song Q; Song H; Xu J; Huang J; Hu M; Gu X; Chen J; Zheng G; Chen H; Gao X
Mol Pharm; 2016 Nov; 13(11):3976-3987. PubMed ID: 27700119
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxicity, uptake and accumulation of selenium nanoparticles and other selenium species in neuroblastoma cell lines related to Alzheimer's disease by using cytotoxicity assays, TEM and single cell-ICP-MS.
Vicente-Zurdo D; Gómez-Gómez B; Romero-Sánchez I; Rosales-Conrado N; León-González ME; Madrid Y
Anal Chim Acta; 2023 Apr; 1249():340949. PubMed ID: 36868776
[TBL] [Abstract][Full Text] [Related]
15. Biogenic Selenium Nanoparticles Attenuate Aβ
Qiao L; Chen Y; Dou X; Song X; Xu C
Neurotox Res; 2022 Dec; 40(6):1869-1881. PubMed ID: 36435923
[TBL] [Abstract][Full Text] [Related]
16. Dual-functional nanoparticles for precise drug delivery to Alzheimer's disease lesions: Targeting mechanisms, pharmacodynamics and safety.
Zheng X; Zhang C; Guo Q; Wan X; Shao X; Liu Q; Zhang Q
Int J Pharm; 2017 Jun; 525(1):237-248. PubMed ID: 28432017
[TBL] [Abstract][Full Text] [Related]
17. Gold nanoparticle-capped mesoporous silica-based H
Yang L; Yin T; Liu Y; Sun J; Zhou Y; Liu J
Acta Biomater; 2016 Dec; 46():177-190. PubMed ID: 27619837
[TBL] [Abstract][Full Text] [Related]
18. TNF-α and IL-1β Modulate Blood-Brain Barrier Permeability and Decrease Amyloid-β Peptide Efflux in a Human Blood-Brain Barrier Model.
Versele R; Sevin E; Gosselet F; Fenart L; Candela P
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142143
[TBL] [Abstract][Full Text] [Related]
19. The effects of polyvinyl alcohol-coated selenium nanoparticles on memory impairment in rats.
Hashemi-Firouzi N; Afshar S; Asl SS; Samzadeh-Kermani A; Gholamigeravand B; Amiri K; Majidi M; Shahidi S
Metab Brain Dis; 2022 Dec; 37(8):3011-3021. PubMed ID: 36271966
[TBL] [Abstract][Full Text] [Related]
20. Cellular uptake of PLGA nanoparticles targeted with anti-amyloid and anti-transferrin receptor antibodies for Alzheimer's disease treatment.
Loureiro JA; Gomes B; Fricker G; Coelho MAN; Rocha S; Pereira MC
Colloids Surf B Biointerfaces; 2016 Sep; 145():8-13. PubMed ID: 27131092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
